Skip to content
Review Open access

Pediatric occipital lobe epilepsy: A modern review of etiological classification, management, and outcomes

Sep 2026 · World Journal of Clinical Pediatrics · Vol 15 · 0 citations · 52 references
Medicine

TL;DR

This review examines the evolving landscape of pediatric OLE, highlighting the shift from syndromic to etiological classification and management strategies and the need to monitor cognitive comorbidities and syndrome evolution.

Abstract

Pediatric occipital lobe epilepsy (OLE) comprises syndromes with seizures originating from the posterior cerebral cortex. Previously “benign”, recent International League Against Epilepsy (ILAE) updates reclassified these as self-limited or structural focal epilepsies, reflecting their complex causes and morbidity potential. The 2017 ILAE guidelines shifted from syndromic recognition to an etiology-driven approach. High-resolution magnetic resonance imaging is crucial to differentiate self-limited genetic syndromes from structural OLE (e.g., focal cortical dysplasia), as the latter often requires surgery. Self-limited epilepsy with autonomic seizures (formerly Panayiotopoulos syndrome) presents with prolonged nocturnal autonomic seizures. Childhood occipital visual epilepsy (previously Gastaut type) manifests as frequent, brief daytime visual hallucinations. Despite high seizure freedom rates with monotherapy, patients face neurocognitive challenges in visuospatial processing and academic performance. For drug-resistant structural cases, surgery offers high seizure freedom rates, though with risk of visual deficits. Accurate differentiation between idiopathic and structural OLE is essential for improving outcomes. The shift from “benign” to “self-limited” terminology emphasizes the need to monitor cognitive comorbidities and syndrome evolution. Early diagnosis is critical to avoid clinical mimics and enhance neurodevelopmental outcomes. This review examines the evolving landscape of pediatric OLE, highlighting the shift from syndromic to etiological classification and management strategies.

Read PDF

Similar papers

Open access 2026

Paediatric Epilepsy: Current Advances in Diagnosis and Management

Comprehensive care extends beyond seizure management and includes addressing developmental, educational, and psychosocial needs, and a multidisciplinary, family-centred approach involving neurologists, dietitians, psychologists, and educators is essential.

Jayesh S. Patil, Hitendra S. Chaudhari, S. Pawar et al. · 0 citations
Jul 2026

Pediatric Epilepsy: Current Perspectives and Emerging Therapies

0.5–1% of children worldwide suffer from epilepsy, a widespread neurological condition that affects people of all genders and demographics. It is a collection of disorders rather than a single illness that is typified by frequent, erratic seizures brought on by aberrant brain activity. These seizures can take many diff...

N. P. Patil, Divakar. R. Patil, Akash S. Jain et al. · 0 citations
Review

strategy for temporal lobe epilepsy with dual pathology and incomplete evidence from EEG and neuroimaging

Patients with resection of the sclerotic hippocampus and neocortical lesion had improved seizure‑free outcomes compared with patients who received individual lesion resection, providing a novel surgical strategy for neurosurgeons treating epileptic patients with dual pathology.

Lan Luan, Yuqiang Sun, Kang Yang · 0 citations
Review Open access Aug 2026

Severe Epilepsy Syndromes in Childhood: A Comprehensive Review of Clinical Features, Etiologies, and Advancing Therapeutic Landscapes

This critical narrative review synthesises evidence on the clinical features, aetiologies, and therapeutic options for these syndromes, and evaluates the strength, consistency, and limitations of that evidence rather than cataloguing individual studies.

S. Bittmann, E. Luchter, E. Moschuring-Alieva · 0 citations
Review Open access Aug 2026

Early infantile developmental and epileptic encephalopathy: clinical spectrum, diagnosis, outcomes, and evolving treatment strategies.

Critical unmet needs include earlier molecular diagnosis, precision therapies targeting developmental outcomes beyond seizure control, and prospective international registries to characterize the long-term natural history of EIDEE.

Debopam Samanta · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.